Microphthalmia Transcription Factor Is a Target of the p38 MAPK Pathway in Response to Receptor Activator of NF-κB Ligand Signaling
Open Access
- 1 March 2002
- journal article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 277 (13), 11077-11083
- https://doi.org/10.1074/jbc.m111696200
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Linkage of M-CSF Signaling to Mitf, TFE3, and the Osteoclast Defect in Mitfmi/mi MiceMolecular Cell, 2001
- Involvement of p38 Mitogen-activated Protein Kinase Signaling Pathway in Osteoclastogenesis Mediated by Receptor Activator of NF-κB Ligand (RANKL)Online Journal of Public Health Informatics, 2000
- Bone Resorption by OsteoclastsScience, 2000
- The Microphthalmia Transcription Factor Regulates Expression of the Tartrate-Resistant Acid Phosphatase Gene During Terminal Differentiation of OsteoclastsJournal of Bone and Mineral Research, 2000
- Pyridinylimidazole Compound SB 203580 Inhibits the Activity but Not the Activation of p38 Mitogen-Activated Protein KinaseBiochemical and Biophysical Research Communications, 1999
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Characterization of the Structure and Function of a New Mitogen-activated Protein Kinase (p38β)Online Journal of Public Health Informatics, 1996
- A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian CellsScience, 1994
- PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activityNeuron, 1992
- Fusion disability of embryonic osteoclast precursor cells and macrophages in the microphthalmic osteopetrotic mouseBone, 1985